Viewing data from:

ARFORMOTEROL TARTRATE

ANDA

ARFORMOTEROL TARTRATE | A207306 | CIPLA LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.6429

per ml

Lowest NADAC/Unit

$0.6145

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69097016864ARFORMOTEROL 15 MCG/2 ML SOLN	$0.6429	ML	Generic	—	2026-08-19
69097016853ARFORMOTEROL 15 MCG/2 ML SOLN	$0.6145	ML	Generic	—	2026-08-19
69097016887ARFORMOTEROL 15 MCG/2 ML SOLN	$0.6145	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs

4 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDARFORMOTEROL TARTRATE

DMF 229682009

MSN LABORATORIES PRIVATE LTDARFORMOTEROL TARTRATE [ROUTE CODE - "LT"]

DMF 280132014

ALIVUS LIFE SCIENCES LTDARFORMOTEROL TARTRATE

DMF 288682015

INKE SAARFORMOTEROL TARTRATE (FORM D)

DMF 329902018

INKE SAARFORMOTEROL TARTRATE (FORM A)

DMF 364352022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jul 7, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 0.015MG BASE/2ML

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Jun 22, 2021

No patent or exclusivity listings for this strength.